Petra Glander

Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.

Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.

Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation.

FTY720 (fingolimod) in renal transplantation.

Pharmacokinetic principles of immunosuppressive drugs.

Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.

Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients.

Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.

Target enzyme activity as a biomarker for immunosuppression.

Enteric-coated mycophenolate sodium.

Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantation.

Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiography.

Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.

Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.

Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.

Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.